The dynamics of T cells during persistent Staphylococcus aureus infection: From antigen-reactivity to in vivo anergy

EMBO Molecular Medicine

Volumn 3, Issue 11, 2011, Pages 652-666

  Ziegler, Christina ^a   Goldmann, Oliver ^a   Hobeika, Elias ^b   Geffers, Robert ^a   Peters, Georg ^c   Medina, Eva ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Immunosuppressive mechanisms; Persistent infection; Staphylococcus aureus; T cell anergy; T cell responses

Indexed keywords

CARRAGEENAN; PHORBOL ESTER; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENIC MODULATION; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, BACTERIAL; CLONAL ANERGY; FEMALE; HUMANS; KIDNEY; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES;

EID: 80155167213     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201100173     Document Type: Article

References (44)

1. Anderson K, Czinn S, Redline R, Blanchard T (2006) Induction of CTLA-4 mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J Immunol 176: 5306-5313
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29
3. Boucher HW, Corey GR (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46: S344- S349
4. Cheng AG, Kim HK, Burts ML, Krausz T, Schneewind O, Missiakas DM (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 23: 3393-3404
5. Chiodetti L, Choi S, Barber DL, Schwartz RH (2006) Adaptive tolerance and clonal anergy are distinct biochemical states. J Immunol 176: 2279-2291
6. Choi S, Schwartz RH (2007) Molecular mechanisms for adaptive tolerance and other T cell anergy models. Semin Immunol 19: 140-152
7. + T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 170: 1958-1963
8. Deleo FR, Otto M, Kreiswirth BN, Chambers HF (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568
9. Essery G, Feldmann M, Lamb JR (1988) Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 64: 413-417
10. Garzoni C, Kelley WL (2009) Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol 17: 59-65
11. Goodyear CS, Silverman GJ (2004) Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proc Natl Acad Sci USA 101: 11392-11397
12. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT (1998) A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391: 799-803
13. Huang SS, Platt R (2003) Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36: 281-285
14. Huang SS, Diekema DJ, Warren DK, Zuccotti G, Winokur PL, Tendolkar S, Boyken L, Datta R, Jones RM, Ward MA, et al (2008) Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis 46: 1241-1247
15. Jin HT, Jeong YH, Park HJ, Ha SJ (2011) Mechanism of T cell exhaustion in a chronic environment. BMB Rep 44: 217-231
16. Jonsson IM, Arvidson S, Foster S, Tarkowski A (2004) Sigma factor B and Rsbu are required for virulence in Staphylococcus aureus induced arthritis and sepsis. Infect Immun 72: 6106-6111
17. Klenerman P, Hill A (2005) T cells and viral persistence: lessons from diverse infections. Nat Immunol 6: 873-879
18. Kluytmans J, van Belkum A, Verbrugh H (1991) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10: 505-520
19. Kobayashi Y (2008) The role of chemokines in neutrophil biology. Front Biosci 13: 2400-2407
20. Lee LY, Miyamoto YJ, McIntyre BW, Höök M, McCrea KW, McDevitt D, Brown EL (2002) The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest 110: 1461-1471
21. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM (1995) Human Mig chemokine: biochemical and functional characterization. J Exp Med 182: 1301-1314
22. Llewelyn M, Cohen J (2002) Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2: 156-162
23. + T lymphocytes. FASEB J 8: 1055-1060
24. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532
25. + T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci USA 103: 10408-10413
26. Miller C, Ragheb JA, Schwartz RH (1999) Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo. J Exp Med 190: 53-64
27. Mölne L, Verdrengh M, Tarkowski A (2000) Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun 68: 6162-6167
28. Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B (2010) Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 50: 979-987
29. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD (1995) Persistent and relapsing infections associated with small colony variants of Staphylococcus aureus. Clin Infect Dis 20: 95-102
30. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, Peters G (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4: 295-305
31. Rich RR, Fleisher TA, Shearer WT, Kotzin BL, Schroeder HWJ (eds), (2001) Clinical Immunology: Prinicples and Practice, 2nd ed. New York: Mosby.
32. Rollins BJ (1997) Chemokines. Blood 90: 909-928
33. Schmaler M, Jann NJ, Ferracin F, Landmann R (2011) T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation. J Immunol 186: 443-452
34. Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21: 305-334
35. Sheehy SH, Atkins BA, Bejon P, Byren I, Wyllie D, Athanasou NA, Berendt AR, McNally MA (2010) The microbiology of chronic osteomyelitis: prevalence of resistance to common empirical anti-microbial regimens. J Infect 60: 338-343
36. Smith-Garvin JE, Koretzky GA, Jordan MS (2009) T cell activation. Annu Rev Immunol 27: 591-619
37. Spellberg B, Ibrahim AS, Yeaman MR, Lin L, Fu Y, Avanesian V, Bayer AS, Filler SG, Lipke P, Otoo H, s et al (2008) The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun 76: 4574-4580
38. Stadecker MJ (1992) The role of T-cell anergy in the immunomodulation of schistosomiasis. Parasitol Today 8: 199-204
39. Syrbe U, Siveke J, Hamann A (1999) Th1/Th2 subsets: Distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol 21: 263-285
40. Tuchscherr L, Medina E, Hussain M, Völker W, Heitmann V, Niemann S, Holzinger D, Roth J, Proctor RA, Becker K, et al (2011) Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 3: 129-141
41. Tzianabos AO, Chandraker A, Kalka-Moll W, Stingele F, Dong VM, Finberg RW, Peach R, Sayegh MH (2000) Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway. Infect Immun 68: 6650-6655
42. Verdrengh M, Tarkowski A (1997) Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 65: 2517-2521
43. von Köckritz-Blickwede M, Rohde M, Oehmcke S, Miller LS, Cheung AL, Herwald H, Foster S, Medina E (2008) Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am J Pathol 173: 1657-1668
44. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364: 703-705